GLP-1s must now include warning for potential increased risk of vision loss, FDA announces
The FDA announced that GLP-1 weight loss drugs will now include warning labels indicating a potential increased risk of vision loss.
We haven't written up this one. CBS News has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.